Summary:
This is a Phase 3, randomized, double-blind, saline placebo- and active-controlled, multicenter study to evaluate the analgesic efficacy, safety, and PK of HTX-011 administered via local administration into the surgical site in subjects undergoing unilateral simple bunionectomy.
Qualified Participants Must:
• Be able to provide written informed consent, adhere to the study visit schedule, and complete all study assessments.
•
Be male or female, and 18 years of age or older at screening.
•
Have a bunion on the first metatarsal (big toe) requiring surgical interveion.
Qualified Participants May Receive:
Free medical testing, free medical evaluations, free surgery, free medications, compensation for time and travel.